speb/financial-data huggingface dataset:
Financial ratios for GRN.TO — annual report dated 2025-12-31
Total revenue: 32431386.861313865
Gross profit: 13242335.766423356
Operating income: 281021.897810219
Net income: -760583.9416058394
Capital expenditures: 456934.306569343
Operating cash flow: 910218.9781021897
Depreciation & amortization: 866423.3576642335
Net tangible assets: 9667153.284671532
Owner earnings: -351094.8905109489
Return on net tangible assets (%): -3.631833282996074
Capex to operating income (%): 162.59740259740258
Buffett classification: The Gruesome
Stock price: 0.1678832116788321
Shares outstanding: 159622553
Book value: 17280291.970802914
P/B ratio: 1.550780906902087
Market cap (USD): 26797946.854014598
Debt to equity: 0.11248627185942386
Current ratio: 1.6076306196840826
Quick ratio: 1.5232077764277034
Effective tax rate (%): 195.4212454212454
Interest coverage ratio: 2.3333333333333335
COGS to revenue (%): 59.16814836488038
R&D to revenue (%): 4.2740428979766385
SG&A to revenue (%): 35.265917940176905
Free cash flow (dilution-adjusted): 156204.37956204382
Buyback yield (%): 0
Retained earnings: -35151094.89051095
Inventory turnover: 15.134715025906734
Receivables turnover: 3.6240619902120716
Capitalized R&D asset: 1748947.8204277474
ROCI (R&D-adjusted, %): 4.492066808033104
Rosenberg metric: 8.521995489015568
FCF margin (%): 0.4816456978235918
Revenue growth (%): -10.503891911079082
Rule of 40 score: -10.02224621325549
Financial ratios for IEM.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.07040540540540541
Shares outstanding: 38859208
Market cap (USD): 2735898.292972973
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IEM.L — annual report dated 2022-12-31
Total revenue: -264737349.39759037
Net income: -270204819.27710843
Capital expenditures: 0
Operating cash flow: 6174698.795180723
Net tangible assets: 1537274698.7951808
Owner earnings: -270204819.27710843
Return on net tangible assets (%): -17.57687285745859
Buffett classification: The Gruesome
Stock price: 0.04843373493975903
Shares outstanding: 38859208
Book value: 1537274698.7951808
P/B ratio: 0.0012243072638325684
Market cap (USD): 1882096.5802409635
Debt to equity: 0.040445538889820665
Free cash flow (dilution-adjusted): 6174698.795180723
Buyback yield (%): 0
Receivables turnover: -354.4064516129032
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IEM.L — annual report dated 2023-12-31
Total revenue: 65530379.74683544
Net income: 61388607.594936706
Capital expenditures: 0
Operating cash flow: 10211392.40506329
Net tangible assets: 1547448101.2658226
Owner earnings: 61388607.594936706
Return on net tangible assets (%): 3.967086685797115
Buffett classification: The Gruesome
Stock price: 0.048987341772151895
P/E ratio: 0.031009162414169945
Shares outstanding: 38859208
Book value: 1547448101.2658226
P/B ratio: 0.0012301603535097392
Market cap (USD): 1903609.3032911392
Debt to equity: 0.07124592223701906
Effective tax rate (%): 2.9380566396477534
COGS to revenue (%): 0
SG&A to revenue (%): 3.382333056462362
Free cash flow (dilution-adjusted): 10211392.40506329
Buyback yield (%): 0
Receivables turnover: 68.84175531914893
Capitalized R&D asset: 0
FCF margin (%): 15.582684618207807
Rule of 40 score: 15.582684618207807
Financial ratios for IEM.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1285105000
Buffett classification: The Gruesome
Stock price: 0.04712499999999999
Shares outstanding: 38859208
Book value: 1285105000
P/B ratio: 0.0014249731944082388
Market cap (USD): 1831240.1769999997
Debt to equity: 0.08084553402251178
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IEM.L — annual report dated 2024-12-31
Total revenue: -20835000
Net income: -25807500
Capital expenditures: 0
Operating cash flow: 10340000
Net tangible assets: 1285105000
Owner earnings: -25807500
Return on net tangible assets (%): -2.0082016644554335
Buffett classification: The Gruesome
Stock price: 0.04712499999999999
Shares outstanding: 38859208
Book value: 1285105000
P/B ratio: 0.0014249731944082388
Market cap (USD): 1831240.1769999997
Debt to equity: 0.08084553402251178
Free cash flow (dilution-adjusted): 10340000
Buyback yield (%): 0
Receivables turnover: -4.204843592330978
Capitalized R&D asset: 0
Revenue growth (%): -131.7944136452317
Rule of 40 score: -131.7944136452317
Financial ratios for IEM.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1168221917.8082192
Buffett classification: The Gruesome
Stock price: 0.05041095890410959
Shares outstanding: 38859208
Book value: 1168221917.8082194
P/B ratio: 0.0016768474445416402
Market cap (USD): 1958929.9375342466
Debt to equity: 0.10121106657817404
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INMD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 70.58
Shares outstanding: 57480772
Market cap (USD): 4056992887.7599998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INMD — annual report dated 2022-12-31
Total revenue: 129054261.36363636
Gross profit: 108177840.9090909
Operating income: 56208522.72727273
Net income: 45886363.63636363
Capital expenditures: 447443.1818181818
Operating cash flow: 51584659.09090909
Depreciation & amortization: 193181.81818181818
Net tangible assets: 157561931.8181818
Owner earnings: 45632102.27272727
Return on net tangible assets (%): 28.9613752168159
Capex to operating income (%): 0.7960415255693594
Buffett classification: The Great
Stock price: 35.7
P/E ratio: 44.72055307459139
Shares outstanding: 57480772
Book value: 157561931.8181818
P/B ratio: 13.02385377432395
Market cap (USD): 2052063560.4
Debt to equity: 0.008946698448301354
Current ratio: 7.67338454035601
Quick ratio: 7.18695440136552
Effective tax rate (%): 19.82766322853484
COGS to revenue (%): 16.176467350986528
R&D to revenue (%): 2.735151484466321
SG&A to revenue (%): 37.534203151863096
Free cash flow (dilution-adjusted): 44190625
Buyback yield (%): 0.5902733387336208
Retained earnings: 140769034.0909091
Inventory turnover: 1.841867809609745
Receivables turnover: 16.071855651866265
Capitalized R&D asset: 3529829.5454545454
ROCI (R&D-adjusted, %): 35.86157145325851
FCF margin (%): 34.24189525635579
Rule of 40 score: 34.24189525635579
Financial ratios for INMD — annual report dated 2023-12-31
Total revenue: 135924861.87845305
Gross profit: 113629834.25414364
Operating income: 54049723.75690608
Net income: 54673756.90607735
Capital expenditures: 194751.38121546962
Operating cash flow: 48846961.32596685
Depreciation & amortization: 172099.44751381216
Net tangible assets: 217506077.3480663
Owner earnings: 54651104.97237569
Return on net tangible assets (%): 25.12624274167738
Capex to operating income (%): 0.3603189205765103
Buffett classification: The Great
Stock price: 22.24
P/E ratio: 23.381827802250413
Shares outstanding: 57480772
Book value: 217506077.3480663
P/B ratio: 5.877409886043192
Market cap (USD): 1278372369.28
Debt to equity: 0.011452020137876379
Current ratio: 13.180273169514782
Quick ratio: 12.477157914431833
Effective tax rate (%): 8.905171977336641
COGS to revenue (%): 16.40246480018209
R&D to revenue (%): 2.72534386889084
SG&A to revenue (%): 41.107778102949304
Free cash flow (dilution-adjusted): 42132872.9281768
Buyback yield (%): 0
Retained earnings: 191554143.64640883
Inventory turnover: 1.7897327863399488
Receivables turnover: 11.278003163033764
Capitalized R&D asset: 6069405.684957308
ROCI (R&D-adjusted, %): 24.398427478895897
Rosenberg metric: 1.5445486176728873
FCF margin (%): 30.997179136994763
Revenue growth (%): 5.323807553674951
Rule of 40 score: 36.32098669066971
Financial ratios for INMD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.95
Shares outstanding: 57480772
Market cap (USD): 974299085.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INMD — annual report dated 2024-12-31
Total revenue: 108169315.06849316
Gross profit: 86867397.26027398
Operating income: 30830410.95890411
Net income: 49664383.56164384
Capital expenditures: 183287.67123287672
Operating cash flow: 36346301.36986301
Depreciation & amortization: 199452.05479452055
Net tangible assets: 192825479.4520548
Owner earnings: 49680547.94520548
Return on net tangible assets (%): 25.764514153617508
Capex to operating income (%): 0.5945028481040779
Buffett classification: The Great
Stock price: 16.7
P/E ratio: 19.32831585855744
Shares outstanding: 57480772
Book value: 192825479.4520548
P/B ratio: 4.978226399995453
Market cap (USD): 959928892.4
Debt to equity: 0.011113747543736759
Current ratio: 10.228228658143763
Quick ratio: 9.37572833602955
Effective tax rate (%): -26.351337222675287
COGS to revenue (%): 19.693124426951155
R&D to revenue (%): 3.3273558956278593
SG&A to revenue (%): 48.47752635391496
Free cash flow (dilution-adjusted): 31623561.64383562
Buyback yield (%): 8.145152401590192
Retained earnings: 239644109.5890411
Inventory turnover: 1.305702962316115
Receivables turnover: 9.617743782124675
Capitalized R&D asset: 7245983.158158632
ROCI (R&D-adjusted, %): 15.154628855060578
Rosenberg metric: -7.224460993125144
FCF margin (%): 29.235242567461462
Revenue growth (%): -20.419771943398775
Rule of 40 score: 8.815470624062687
Financial ratios for INMD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.7
Shares outstanding: 57480772
Market cap (USD): 959928892.4
Buyback yield (%): 0
Retained earnings: 239644109.5890411
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INMD — quarterly report dated 2025-03-31
Total revenue: 21104065.040650405
Gross profit: 16507046.070460705
Operating income: 4232520.325203252
Net income: 4932520.325203252
Capital expenditures: 23035.230352303523
Operating cash flow: 3805962.0596205965
Depreciation & amortization: 47154.471544715445
Net tangible assets: 167866666.66666666
Owner earnings: 4956639.566395664
Return on net tangible assets (%): 2.952724126129268
Capex to operating income (%): 0.5442438212319118
Buffett classification: The Great
Stock price: 17.74
P/E ratio: 51.68295455721114
Shares outstanding: 57480772
Book value: 167866666.66666666
P/B ratio: 6.074516850357426
Market cap (USD): 1019708895.2799999
Debt to equity: 0.009021226034341362
Current ratio: 8.734578435960254
Quick ratio: 7.85675355776377
Effective tax rate (%): 19.023891088668414
COGS to revenue (%): 21.78262321185505
R&D to revenue (%): 3.7175437244780034
SG&A to revenue (%): 54.44435883606852
Free cash flow (dilution-adjusted): 3100542.0054200543
Buyback yield (%): 2.6565847390073527
Inventory turnover: 0.2659569464260516
Receivables turnover: 1.3442543715799828
Capitalized R&D asset: 784552.8455284553
ROCI (R&D-adjusted, %): 2.7635864258581484
FCF margin (%): 14.691681434111514
Rule of 40 score: 14.691681434111514
Financial ratios for INMD — quarterly report dated 2025-06-30
Total revenue: 28201179.94100295
Gross profit: 22551622.418879054
Operating income: 6749557.522123894
Net income: 7888495.575221239
Capital expenditures: 64601.76991150442
Operating cash flow: 7100884.955752213
Depreciation & amortization: 56342.18289085545
Net tangible assets: 185379646.01769912
Owner earnings: 7880235.98820059
Return on net tangible assets (%): 4.250863650612551
Capex to operating income (%): 0.9571259997377737
Buffett classification: The Great
Stock price: 14.44
P/E ratio: 64.73920273763319
Shares outstanding: 57480772
Book value: 185379646.0176991
P/B ratio: 4.477418991299367
Market cap (USD): 830022347.68
Debt to equity: 0.009711395096087596
Current ratio: 9.60082063305979
Quick ratio: 8.577133495656355
Effective tax rate (%): 13.576576285428043
COGS to revenue (%): 20.0330537018054
R&D to revenue (%): 3.5271228635384193
SG&A to revenue (%): 52.50622371916906
Free cash flow (dilution-adjusted): 6028023.598820059
Buyback yield (%): 0.9767658249117513
Inventory turnover: 0.2811921891058582
Receivables turnover: 1.5936854037474162
Capitalized R&D asset: 1520340.6719907909
ROCI (R&D-adjusted, %): 3.747087487373693
Rosenberg metric: 7.70448591560059
FCF margin (%): 21.37507583523357
Revenue growth (%): 33.62913678801769
Rule of 40 score: 55.00421262325126
Financial ratios for INMD — quarterly report dated 2025-09-30
Total revenue: 28146525.679758307
Gross profit: 21845619.335347433
Operating income: 6313293.051359517
Net income: 6605135.951661631
Capital expenditures: 40483.3836858006
Operating cash flow: 7391842.900302115
Depreciation & amortization: 47129.90936555891
Net tangible assets: 197397280.96676737
Owner earnings: 6611782.47734139
Return on net tangible assets (%): 3.349480015611011
Capex to operating income (%): 0.6412403694310188
Buffett classification: The Great
Stock price: 14.9
P/E ratio: 44.088170900817225
Shares outstanding: 57480772
Book value: 197397280.96676737
P/B ratio: 4.338780648879299
Market cap (USD): 856463502.8000001
Debt to equity: 0.008560037343985551
Current ratio: 9.751075662227427
Quick ratio: 8.706102736718865
Effective tax rate (%): 14.657662580997735
COGS to revenue (%): 22.3860891965867
R&D to revenue (%): 3.802930284978265
SG&A to revenue (%): 51.380883378951324
Free cash flow (dilution-adjusted): 6536858.006042296
Buyback yield (%): 0
Inventory turnover: 0.2920885677072392
Receivables turnover: 1.4887344199424737
Capitalized R&D asset: 1995737.6661452092
ROCI (R&D-adjusted, %): 3.1648843102831052
Rosenberg metric: -0.7097717832657765
FCF margin (%): 23.224386840551713
Revenue growth (%): -0.19380132802592143
Rule of 40 score: 23.030585512525793
Financial ratios for INMD — annual report dated 2025-12-31
Total revenue: 116507861.63522013
Gross profit: 91500000
Operating income: 26851257.86163522
Net income: 29506603.773584906
Capital expenditures: 305660.37735849054
Operating cash flow: 26810377.358490564
Depreciation & amortization: 218553.45911949684
Net tangible assets: 214842138.36477986
Owner earnings: 29419496.855345912
Return on net tangible assets (%): 13.693541257439279
Capex to operating income (%): 1.1383465867169476
Buffett classification: The Great
Stock price: 14.69
P/E ratio: 28.617069831531158
Shares outstanding: 57480772
Book value: 214842138.3647799
P/B ratio: 3.9302929448891826
Market cap (USD): 844392540.68
Debt to equity: 0.012041897078153039
Current ratio: 9.875339251385276
Quick ratio: 8.82860737306344
Effective tax rate (%): 14.95422822441766
COGS to revenue (%): 21.46452718660171
R&D to revenue (%): 3.5949203093159148
SG&A to revenue (%): 51.89381773033374
Free cash flow (dilution-adjusted): 23004402.51572327
Buyback yield (%): 4.746220226847828
Retained earnings: 304569811.3207547
Inventory turnover: 1.073936529372046
Receivables turnover: 7.517856418164847
Capitalized R&D asset: 7822272.6584786195
ROCI (R&D-adjusted, %): 12.007957734348876
Rosenberg metric: 1.2871279591992066
FCF margin (%): 19.74493582909351
Revenue growth (%): 7.708791131243618
Rule of 40 score: 27.45372696033713
Financial ratios for INMD — quarterly report dated 2025-12-31
Total revenue: 32658490.566037733
Gross profit: 25566037.735849056
Operating income: 8173270.440251572
Net income: 8498427.672955975
Capital expenditures: 167924.52830188678
Operating cash flow: 7130188.679245283
Depreciation & amortization: 54716.98113207547
Net tangible assets: 214842138.36477986
Owner earnings: 8385220.125786163
Return on net tangible assets (%): 3.902968100023712
Capex to operating income (%): 2.0545573467738834
Buffett classification: The Great
Stock price: 14.69
P/E ratio: 30.238326056897968
Shares outstanding: 57480772
Book value: 214842138.3647799
P/B ratio: 3.9302929448891826
Market cap (USD): 844392540.68
Debt to equity: 0.012041897078153039
Current ratio: 9.875339251385276
Quick ratio: 8.82860737306344
Effective tax rate (%): 13.636073117729772
COGS to revenue (%): 21.717025824715467
R&D to revenue (%): 3.378781751304716
SG&A to revenue (%): 49.87771294317022
Free cash flow (dilution-adjusted): 6176415.094339622
Buyback yield (%): 0
Retained earnings: 304569811.3207547
Inventory turnover: 0.30457798784604995
Receivables turnover: 2.1073414228318654
Capitalized R&D asset: 2148870.0491014323
ROCI (R&D-adjusted, %): 3.7210904492061463
Rosenberg metric: 3.4757507495513336
FCF margin (%): 18.912126639320583
Revenue growth (%): 16.03027292822938
Rule of 40 score: 34.94239956754996
Financial ratios for KOP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.2
Shares outstanding: 19231826
Market cap (USD): 580801145.1999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KOP — annual report dated 2022-12-31
Total revenue: 1980500000
Gross profit: 344600000
Operating income: 135200000
Net income: 63400000
Capital expenditures: 105300000
Operating cash flow: 102300000
Depreciation & amortization: 56100000
Net tangible assets: -10700000
Owner earnings: 14200000
Return on net tangible assets (%): -132.71028037383178
Capex to operating income (%): 77.88461538461539
Buffett classification: The Gruesome
Stock price: 27.41
P/E ratio: 8.31457966340694
Shares outstanding: 19231826
Book value: 403000000
P/B ratio: 1.3080504979156329
Market cap (USD): 527144350.66
Debt to equity: 2.2444168734491314
Current ratio: 1.9654320987654321
Quick ratio: 0.8675925925925926
Effective tax rate (%): 33.123689727463315
Interest coverage ratio: 3.017857142857143
COGS to revenue (%): 82.60035344609948
SG&A to revenue (%): 7.740469578389296
Free cash flow (dilution-adjusted): -16200000
Buyback yield (%): 4.476952085411162
Retained earnings: 360200000
Inventory turnover: 4.5991003654765255
Receivables turnover: 9.181733889661567
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.744846475421651
FCF margin (%): -0.8179752587730371
Rule of 40 score: -0.8179752587730371
Financial ratios for KOP — annual report dated 2023-12-31
Total revenue: 2154200000
Gross profit: 424500000
Operating income: 193400000
Net income: 89800000
Capital expenditures: 120500000
Operating cash flow: 146100000
Depreciation & amortization: 57000000
Net tangible assets: 102300000
Owner earnings: 26300000
Return on net tangible assets (%): 25.708699902248288
Capex to operating income (%): 62.306101344364016
Buffett classification: The Good
Stock price: 50.12
P/E ratio: 10.733843197327392
Shares outstanding: 19231826
Book value: 503000000
P/B ratio: 1.9163004356262425
Market cap (USD): 963899119.12
Debt to equity: 1.8502982107355865
Current ratio: 2.144829702362688
Quick ratio: 0.9306535747161706
Effective tax rate (%): 27.929373996789725
Interest coverage ratio: 2.723943661971831
COGS to revenue (%): 80.29430879212701
SG&A to revenue (%): 8.081886547210102
Free cash flow (dilution-adjusted): 8300000
Buyback yield (%): 2.085280461543576
Retained earnings: 444000000
Inventory turnover: 4.3712408390194595
Receivables turnover: 10.643280632411066
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.811340752517223
FCF margin (%): 0.38529384458267574
Revenue growth (%): 8.770512496844232
Rule of 40 score: 9.155806341426908
Financial ratios for KOP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.91
Shares outstanding: 19231826
Market cap (USD): 690614871.66
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KOP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.91
Shares outstanding: 19231826
Market cap (USD): 613687567.66
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KOP — annual report dated 2024-12-31
Total revenue: 2092100000
Gross profit: 422600000
Operating income: 175800000
Net income: 52400000
Capital expenditures: 77400000
Operating cash flow: 119400000
Depreciation & amortization: 67500000
Net tangible assets: 52600000
Owner earnings: 42500000
Return on net tangible assets (%): 80.79847908745246
Capex to operating income (%): 44.027303754266214
Buffett classification: The Good
Stock price: 31.91
P/E ratio: 11.711594802671756
Shares outstanding: 19231826
Book value: 489000000
P/B ratio: 1.2549848009406952
Market cap (USD): 613687567.66
Debt to equity: 2.0897750511247444
Current ratio: 2.089011663597299
Quick ratio: 0.8471454880294659
Effective tax rate (%): 29.87012987012987
Interest coverage ratio: 2.3070866141732282
COGS to revenue (%): 79.80020075522202
SG&A to revenue (%): 8.57033602600258
Free cash flow (dilution-adjusted): 21200000
Buyback yield (%): 8.27782778681686
Retained earnings: 490300000
Inventory turnover: 4.126297577854671
Receivables turnover: 10.90771637122002
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.237535157248786
FCF margin (%): 1.013335882605994
Revenue growth (%): -2.882740692600501
Rule of 40 score: -1.869404809994507
Financial ratios for KOP — quarterly report dated 2025-03-31
Total revenue: 456500000
Gross profit: 105800000
Operating income: 46700000
Net income: -13900000
Capital expenditures: 14300000
Operating cash flow: -22700000
Depreciation & amortization: 18000000
Net tangible assets: 65100000
Owner earnings: -10200000
Return on net tangible assets (%): -15.668202764976957
Capex to operating income (%): 30.620985010706637
Buffett classification: The Good
Stock price: 27.65
Shares outstanding: 19231826
Book value: 498300000
P/B ratio: 1.0671482819586593
Market cap (USD): 531759988.9
Debt to equity: 2.1456953642384105
Current ratio: 2.6384439359267735
Quick ratio: 1.0999237223493517
Interest coverage ratio: 2.8132530120481927
COGS to revenue (%): 76.8236582694414
SG&A to revenue (%): 9.00328587075575
Free cash flow (dilution-adjusted): -43600000
Buyback yield (%): 3.5918460205158174
Retained earnings: 474500000
Inventory turnover: 0.869360436291522
Receivables turnover: 2.22900390625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8674935527446888
FCF margin (%): -9.55093099671413
Rule of 40 score: -9.55093099671413
Financial ratios for KOP — quarterly report dated 2025-06-30
Total revenue: 504800000
Gross profit: 114200000
Operating income: 56700000
Net income: 16400000
Capital expenditures: 12100000
Operating cash flow: 50500000
Depreciation & amortization: 18000000
Net tangible assets: 96300000
Owner earnings: 22300000
Return on net tangible assets (%): 23.156801661474557
Capex to operating income (%): 21.340388007054674
Buffett classification: The Great
Stock price: 31.83
P/E ratio: 244.85960863199998
Shares outstanding: 19231826
Book value: 527100000
P/B ratio: 1.1613527254410927
Market cap (USD): 612149021.5799999
Debt to equity: 2.029026750142288
Current ratio: 2.6000734484024974
Quick ratio: 1.1112743297833272
Effective tax rate (%): 31.380753138075313
Interest coverage ratio: 3.277456647398844
COGS to revenue (%): 77.37717908082409
SG&A to revenue (%): 7.824881141045958
Free cash flow (dilution-adjusted): 36700000
Buyback yield (%): 1.6499250417702516
Retained earnings: 489300000
Inventory turnover: 0.9634928465712876
Receivables turnover: 2.384506376948512
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4187518842327402
FCF margin (%): 7.270206022187005
Revenue growth (%): 10.580503833515882
Rule of 40 score: 17.85070985570289
Financial ratios for KOP — quarterly report dated 2025-09-30
Total revenue: 485300000
Gross profit: 117000000
Operating income: 61900000
Net income: 23800000
Capital expenditures: 12000000
Operating cash flow: 49600000
Depreciation & amortization: 17600000
Net tangible assets: 120700000
Owner earnings: 29400000
Return on net tangible assets (%): 24.35791217895609
Capex to operating income (%): 19.38610662358643
Buffett classification: The Great
Stock price: 27.8
P/E ratio: 20.328698205323196
Shares outstanding: 19231826
Book value: 545900000
P/B ratio: 0.9793822363070159
Market cap (USD): 534644762.8
Debt to equity: 1.883495145631068
Current ratio: 2.628175519630485
Quick ratio: 1.0873749037721323
Effective tax rate (%): 33.5195530726257
Interest coverage ratio: 3.7065868263473054
COGS to revenue (%): 75.89120131877189
SG&A to revenue (%): 7.727179064496188
Free cash flow (dilution-adjusted): 35200000
Buyback yield (%): 0.7668643340912569
Retained earnings: 511400000
Inventory turnover: 0.9200599550337247
Receivables turnover: 2.5262883914627796
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.7859327217125385
FCF margin (%): 7.253245415207088
Revenue growth (%): -3.862916006339144
Rule of 40 score: 3.390329408867944
Financial ratios for KOP — quarterly report dated 2025-12-31
Total revenue: 432700000
Gross profit: 110800000
Operating income: 54000000
Net income: 29700000
Capital expenditures: 16600000
Operating cash flow: 45100000
Depreciation & amortization: 20000000
Net tangible assets: 137900000
Owner earnings: 33100000
Return on net tangible assets (%): 24.002900652646847
Capex to operating income (%): 30.74074074074074
Buffett classification: The Good
Stock price: 26.96
P/E ratio: 9.258750517142857
Shares outstanding: 19231826
Book value: 574300000
P/B ratio: 0.9028208757792096
Market cap (USD): 518490028.96000004
Debt to equity: 1.7804283475535434
Current ratio: 2.9445178335535007
Quick ratio: 1.133861734918538
Effective tax rate (%): 23.25581395348837
Interest coverage ratio: 3.4838709677419355
COGS to revenue (%): 74.39334411832678
SG&A to revenue (%): 8.504737693552114
Free cash flow (dilution-adjusted): 25400000
Buyback yield (%): 0.9450519250733789
Retained earnings: 539400000
Inventory turnover: 0.7828307392996109
Receivables turnover: 2.726528040327662
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.253600048201482
FCF margin (%): 5.870117864571296
Revenue growth (%): -10.83865650113332
Rule of 40 score: -4.968538636562024
Financial ratios for KOP — annual report dated 2025-12-31
Total revenue: 1879300000
Gross profit: 447800000
Operating income: 219300000
Net income: 56000000
Capital expenditures: 55000000
Operating cash flow: 122500000
Depreciation & amortization: 73600000
Net tangible assets: 137900000
Owner earnings: 74600000
Return on net tangible assets (%): 54.097171863669324
Capex to operating income (%): 25.079799361605108
Buffett classification: The Good
Stock price: 26.96
P/E ratio: 9.258750517142857
Shares outstanding: 19231826
Book value: 574300000
P/B ratio: 0.9028208757792096
Market cap (USD): 518490028.96000004
Debt to equity: 1.7804283475535434
Current ratio: 2.9445178335535007
Quick ratio: 1.133861734918538
Effective tax rate (%): 31.03448275862069
Interest coverage ratio: 3.317700453857791
COGS to revenue (%): 76.17197892832438
SG&A to revenue (%): 8.24243069227904
Free cash flow (dilution-adjusted): 53700000
Buyback yield (%): 7.367547660776137
Retained earnings: 539400000
Inventory turnover: 3.4812743190661477
Receivables turnover: 11.841839949590423
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.213231306862685
FCF margin (%): 2.8574469217261744
Revenue growth (%): -10.1715979159696
Rule of 40 score: -7.314150994243427
Financial ratios for MRM — annual report dated 2021-12-31
Total revenue: 47017425.69094385
Gross profit: 12301503.563358247
Operating income: -3298539.8922301405
Net income: -8610559.707978446
Capital expenditures: 831314.0969928732
Operating cash flow: -4842960.194681036
Depreciation & amortization: 1097192.7689900922
Net tangible assets: -10426820.789153485
Owner earnings: -8344681.035981228
Buffett classification: The Gruesome
Stock price: 6.05
Shares outstanding: 7901950
Book value: -1810733.530331999
Market cap (USD): 47806797.5
Debt to equity: -13.404798817334887
Current ratio: 0.43244601158839757
Quick ratio: 0.42659487503883187
Interest coverage ratio: -31.759832635983262
COGS to revenue (%): 73.83628860452973
SG&A to revenue (%): 33.694010434718315
Free cash flow (dilution-adjusted): -7542690.770033026
Buyback yield (%): 0
Retained earnings: -23414157.830697026
Inventory turnover: 213.57076404854837
Receivables turnover: 6.325135334214126
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.845176461752926
FCF margin (%): -16.04233038961519
Rule of 40 score: -16.04233038961519
Financial ratios for MRM — annual report dated 2022-12-31
Total revenue: 52317612.09750226
Gross profit: 14312797.171230817
Operating income: 884682.5157989769
Net income: 1120711.7062894974
Capital expenditures: 602768.5826060789
Operating cash flow: -5158719.530544689
Depreciation & amortization: 1384712.6090881734
Net tangible assets: -7542446.584411677
Owner earnings: 1902655.7327715917
Return on net tangible assets (%): -25.2259755701008
Capex to operating income (%): 68.1338866589564
Buffett classification: The Good
Stock price: 4.51
P/E ratio: 31.799252475010906
Shares outstanding: 7901950
Book value: -446719.831477575
Market cap (USD): 35637794.5
Debt to equity: -54.41973458183233
Current ratio: 0.6488831447401912
Quick ratio: 0.617551449532629
Effective tax rate (%): 17.137628355602033
Interest coverage ratio: 11.999183673469389
COGS to revenue (%): 72.6424876874032
SG&A to revenue (%): 25.963117644851053
Free cash flow (dilution-adjusted): -6411360.216671683
Buyback yield (%): 0
Retained earnings: -19147366.837195307
Inventory turnover: 44.269952413920024
Receivables turnover: 5.2503063408594155
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.7867197530478562
FCF margin (%): -12.254688162607813
Revenue growth (%): 11.272812853255154
Rule of 40 score: -0.9818753093526595
Financial ratios for MRM — annual report dated 2023-12-31
Total revenue: 48277897.19295765
Gross profit: 11092894.011171604
Operating income: -2617570.52959061
Net income: 815979.6365693276
Capital expenditures: 960475.1467156897
Operating cash flow: -4466782.153715619
Depreciation & amortization: 1786007.2120483632
Net tangible assets: -8445061.160998374
Owner earnings: 1641511.701902001
Return on net tangible assets (%): -19.437534798243444
Buffett classification: The Gruesome
Stock price: 5.72
P/E ratio: 55.3925024281654
Shares outstanding: 7901950
Book value: 1526981.545640953
P/B ratio: 29.60032760646599
Market cap (USD): 45199154
Debt to equity: 16.89781488324281
Current ratio: 0.49393570115989105
Quick ratio: 0.45462146333489956
Effective tax rate (%): -457.8944816215691
Interest coverage ratio: -10.041309536725615
COGS to revenue (%): 77.02283103417822
SG&A to revenue (%): 28.712117251125264
Free cash flow (dilution-adjusted): -10986035.494590962
Buyback yield (%): 0
Retained earnings: 567609.4180866859
Inventory turnover: 37.569651812375874
Receivables turnover: 5.5604813260571975
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.257174794349927
FCF margin (%): -22.755828512335263
Revenue growth (%): -7.7215200437970255
Rule of 40 score: -30.477348556132288
Financial ratios for MRVI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 41.9
Shares outstanding: 147506164
Market cap (USD): 6180508271.599999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MRVI — annual report dated 2022-12-31
Total revenue: 883001000
Gross profit: 714044000
Operating income: 566416000
Net income: 490663000
Capital expenditures: 15985000
Operating cash flow: 535977000
Depreciation & amortization: 38103000
Net tangible assets: 17634000
Owner earnings: 512781000
Return on net tangible assets (%): 2907.9108540319835
Capex to operating income (%): 2.822130730770317
Buffett classification: The Great
Stock price: 14.31
P/E ratio: 4.301961237835338
Shares outstanding: 147506164
Book value: 905243000
P/B ratio: 2.331764185793207
Market cap (USD): 2110813206.8400002
Debt to equity: 0.6465247452893864
Current ratio: 7.698122457873329
Quick ratio: 7.306344421847763
Effective tax rate (%): 11.026670438390344
Interest coverage ratio: 27.746448515724502
COGS to revenue (%): 19.134406416300777
R&D to revenue (%): 2.08029209479944
SG&A to revenue (%): 14.638601768287918
Free cash flow (dilution-adjusted): 500217000
Buyback yield (%): 0
Retained earnings: 404766000
Inventory turnover: 3.915392102335929
Receivables turnover: 6.014419605759668
Capitalized R&D asset: 18369000
ROCI (R&D-adjusted, %): 26.41640873939759
FCF margin (%): 56.64965271840009
Rule of 40 score: 56.64965271840009
Financial ratios for MRVI — annual report dated 2023-12-31
Total revenue: 288945000
Gross profit: 140202000
Operating income: -28468000
Net income: -119029000
Capital expenditures: 52688000
Operating cash flow: 126224000
Depreciation & amortization: 48781000
Net tangible assets: -130263000
Owner earnings: -122936000
Buffett classification: The Gruesome
Stock price: 6.55
Shares outstanding: 147506164
Book value: 789884000
P/B ratio: 1.2231737498164288
Market cap (USD): 966165374.1999999
Debt to equity: 0.7734895250441837
Current ratio: 8.001920702428317
Quick ratio: 7.414311519641469
Effective tax rate (%): 122.40034577877927
Interest coverage ratio: -0.6203259827420902
COGS to revenue (%): 51.47796293412241
R&D to revenue (%): 5.98037688833515
SG&A to revenue (%): 52.39405423177421
Free cash flow (dilution-adjusted): 26083000
Buyback yield (%): 0
Retained earnings: 285737000
Inventory turnover: 2.8940015954238576
Receivables turnover: 5.2915483930043035
Capitalized R&D asset: 29587230
ROCI (R&D-adjusted, %): -1.6138427937484359
Rosenberg metric: -31.23969731613044
FCF margin (%): 9.02697745245635
Revenue growth (%): -67.27693400120725
Rule of 40 score: -58.2499565487509
Financial ratios for MRVI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.31
Shares outstanding: 147506164
Market cap (USD): 1225776222.8400002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MRVI — annual report dated 2024-12-31
Total revenue: 259185000
Gross profit: 108309000
Operating income: -72683000
Net income: -144846000
Capital expenditures: 22516000
Operating cash flow: 7465000
Depreciation & amortization: 56865000
Net tangible assets: -29543000
Owner earnings: -110497000
Buffett classification: The Gruesome
Stock price: 5.45
Shares outstanding: 147506164
Book value: 577209000
P/B ratio: 1.3927513150349355
Market cap (USD): 803908593.8000001
Debt to equity: 0.652609366797815
Current ratio: 7.532709624194766
Quick ratio: 6.653630794614804
Interest coverage ratio: -1.5237526205450733
COGS to revenue (%): 58.21170206609179
R&D to revenue (%): 7.415938422362406
SG&A to revenue (%): 62.415263228967724
Free cash flow (dilution-adjusted): -71608000
Buyback yield (%): 0
Retained earnings: 140891000
Inventory turnover: 3.0125793698334733
Receivables turnover: 6.728582554517134
Capitalized R&D asset: 36860370
ROCI (R&D-adjusted, %): -7.26136796695774
Rosenberg metric: -1.8456597222222222
FCF margin (%): -27.62814206069024
Revenue growth (%): -10.299537974354982
Rule of 40 score: -37.92768003504522
Financial ratios for MRVI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.45
Shares outstanding: 147506164
Market cap (USD): 803908593.8000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MRVI — quarterly report dated 2025-03-31
Total revenue: 46850000
Gross profit: 7725000
Operating income: -36727000
Net income: -29945000
Capital expenditures: 4501000
Operating cash flow: -9390000
Depreciation & amortization: 14910000
Net tangible assets: -58845000
Owner earnings: -19536000
Buffett classification: The Gruesome
Stock price: 2.21
Shares outstanding: 147506164
Book value: 530273000
P/B ratio: 0.6147562150816654
Market cap (USD): 325988622.44
Debt to equity: 0.6989230075828865
Current ratio: 5.957788403685994
Quick ratio: 5.169717217137971
Interest coverage ratio: -5.4185600472115665
COGS to revenue (%): 83.51120597652081
R&D to revenue (%): 10.433297758804695
SG&A to revenue (%): 84.44823906083244
Free cash flow (dilution-adjusted): -24294000
Buyback yield (%): 0
Retained earnings: 110946000
Inventory turnover: 0.7860687521346915
Receivables turnover: 1.644263503316604
Capitalized R&D asset: 4888000
ROCI (R&D-adjusted, %): -3.7125944233248767
FCF margin (%): -51.854855923159015
Rule of 40 score: -51.854855923159015
Financial ratios for MRVI — quarterly report dated 2025-06-30
Total revenue: 47397000
Gross profit: 7768000
Operating income: -35689000
Net income: -39591000
Capital expenditures: 2874000
Operating cash flow: -10265000
Depreciation & amortization: 15386000
Net tangible assets: -56636000
Owner earnings: -27079000
Buffett classification: The Gruesome
Stock price: 2.41
Shares outstanding: 147506164
Book value: 467983000
P/B ratio: 0.7596213008592193
Market cap (USD): 355489855.24
Debt to equity: 0.7769277943856935
Current ratio: 5.162897161390316
Quick ratio: 4.4931833185040615
Interest coverage ratio: -5.236830520909758
COGS to revenue (%): 83.61077705340001
R&D to revenue (%): 10.300229972361121
SG&A to revenue (%): 81.38700761651582
Free cash flow (dilution-adjusted): -20662000
Buyback yield (%): 0
Retained earnings: 71355000
Inventory turnover: 0.8491867915229176
Receivables turnover: 1.69991392296105
Capitalized R&D asset: 8156960
ROCI (R&D-adjusted, %): -4.077327818193959
Rosenberg metric: 0.008797054009819968
FCF margin (%): -43.59347638036163
Revenue growth (%): 1.167556029882604
Rule of 40 score: -42.425920350479025
Financial ratios for MRVI — quarterly report dated 2025-09-30
Total revenue: 41630000
Gross profit: 5655000
Operating income: -33585000
Net income: -25556000
Capital expenditures: 2926000
Operating cash flow: -15150000
Depreciation & amortization: 15443000
Net tangible assets: -69862000
Owner earnings: -13039000
Buffett classification: The Gruesome
Stock price: 2.87
Shares outstanding: 147506164
Book value: 431859000
P/B ratio: 0.9802798845919618
Market cap (USD): 423342690.68
Debt to equity: 0.8519933589435441
Current ratio: 5.292282456881151
Quick ratio: 4.556160067560984
Interest coverage ratio: -4.907218001168907
COGS to revenue (%): 86.41604612058612
R&D to revenue (%): 9.233725678597166
SG&A to revenue (%): 85.02522219553207
Free cash flow (dilution-adjusted): -27132000
Buyback yield (%): 0
Retained earnings: 45799000
Inventory turnover: 0.7936945682389799
Receivables turnover: 1.847184629720016
Capitalized R&D asset: 8727980
ROCI (R&D-adjusted, %): -4.304541481507173
Rosenberg metric: -0.43281442031954115
FCF margin (%): -65.17415325486428
Revenue growth (%): -12.167436757600692
Rule of 40 score: -77.34159001246498
Financial ratios for MRVI — annual report dated 2025-12-31
Total revenue: 185743000
Gross profit: 33990000
Operating income: -128530000
Net income: -130773000
Capital expenditures: 12415000
Operating cash flow: -57573000
Depreciation & amortization: 60472000
Net tangible assets: -68593000
Owner earnings: -82716000
Buffett classification: The Gruesome
Stock price: 3.25
Shares outstanding: 147506164
Book value: 372711000
P/B ratio: 1.286237951120305
Market cap (USD): 479395033
Debt to equity: 0.978527599131767
Current ratio: 6.595520626934123
Quick ratio: 5.693968875926709
Interest coverage ratio: -4.7617812685240075
COGS to revenue (%): 81.7005216885697
R&D to revenue (%): 9.36885912255105
SG&A to revenue (%): 78.12838168867736
Free cash flow (dilution-adjusted): -100896000
Buyback yield (%): 0
Retained earnings: 10118000
Inventory turnover: 3.7474503025064823
Receivables turnover: 7.284610557690799
Capitalized R&D asset: 35982470
ROCI (R&D-adjusted, %): -16.94964130173396
Rosenberg metric: -3.866552208521929
FCF margin (%): -54.32021664342667
Revenue growth (%): -28.335744738314332
Rule of 40 score: -82.65596138174101
Financial ratios for MRVI — quarterly report dated 2025-12-31
Total revenue: 49866000
Gross profit: 12842000
Operating income: -22529000
Net income: -35681000
Capital expenditures: 2114000
Operating cash flow: -22768000
Depreciation & amortization: 14733000
Net tangible assets: -68593000
Owner earnings: -23062000
Buffett classification: The Gruesome
Stock price: 3.25
Shares outstanding: 147506164
Book value: 372711000
P/B ratio: 1.286237951120305
Market cap (USD): 479395033
Debt to equity: 0.978527599131767
Current ratio: 6.595520626934123
Quick ratio: 5.693968875926709
Interest coverage ratio: -3.4369183829138064
COGS to revenue (%): 74.24698191152288
R&D to revenue (%): 7.596358240083425
SG&A to revenue (%): 63.335739782617416
Free cash flow (dilution-adjusted): -28808000
Buyback yield (%): 0
Retained earnings: 10118000
Inventory turnover: 0.9142857142857143
Receivables turnover: 1.9556827986508747
Capitalized R&D asset: 7974540
ROCI (R&D-adjusted, %): -3.1231263093656048
Rosenberg metric: 1.8696670135275755
FCF margin (%): -57.770825813179314
Revenue growth (%): 19.783809752582275
Rule of 40 score: -37.98701606059704
Financial ratios for MTNB — annual report dated 2021-12-31
Capital expenditures: 260000
Buffett classification: The Gruesome
Stock price: 50.5
Shares outstanding: 6406191
Market cap (USD): 323512645.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTNB — annual report dated 2022-12-31
Total revenue: 555981.86
Operating income: -24590000
Net income: -20997000
Capital expenditures: 892000
Operating cash flow: -19156000
Depreciation & amortization: 898000
Net tangible assets: 32284000
Owner earnings: -20991000
Return on net tangible assets (%): -65.01982406145459
Buffett classification: The Gruesome
Stock price: 25
Shares outstanding: 6406191
Book value: 36637000
P/B ratio: 4.371394355433032
Market cap (USD): 160154775
Debt to equity: 0.11256380162131178
Current ratio: 8.056929538030799
Quick ratio: 8.056929538030799
COGS to revenue (%): 0
R&D to revenue (%): 2999.73815692476
SG&A to revenue (%): 1996.468014262192
Free cash flow (dilution-adjusted): -25276000
Buyback yield (%): 0
Retained earnings: -152631000
Capitalized R&D asset: 16678000
ROCI (R&D-adjusted, %): -23.546753829391783
FCF margin (%): -4546.191489053258
Rule of 40 score: -4546.191489053258
Financial ratios for MTNB — annual report dated 2023-12-31
Total revenue: 1096000
Operating income: -23766000
Net income: -22942000
Capital expenditures: 218000
Operating cash flow: -15278000
Depreciation & amortization: 941000
Net tangible assets: 14893000
Owner earnings: -22219000
Return on net tangible assets (%): -149.19089505136643
Buffett classification: The Gruesome
Stock price: 10.8
Shares outstanding: 6406191
Book value: 19246000
P/B ratio: 3.594869728774811
Market cap (USD): 69186862.80000001
Debt to equity: 0.18476566559285046
Current ratio: 5.9279176201373
Quick ratio: 5.9279176201373
COGS to revenue (%): 0
R&D to revenue (%): 1321.9890510948906
SG&A to revenue (%): 946.4416058394161
Free cash flow (dilution-adjusted): -20444000
Buyback yield (%): 0
Retained earnings: -175573000
Capitalized R&D asset: 25663260
ROCI (R&D-adjusted, %): -40.8472194355166
FCF margin (%): -1865.328467153285
Revenue growth (%): 97.1287336604831
Rule of 40 score: -1768.199733492802
Financial ratios for MTNB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.54
Shares outstanding: 6406191
Market cap (USD): 22677916.14
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTNB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.51
Shares outstanding: 6406191
Market cap (USD): 3267157.41
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTNB — annual report dated 2024-12-31
Total revenue: 0
Operating income: -20162000
Net income: -24251000
Capital expenditures: 0
Operating cash flow: -15885000
Depreciation & amortization: 972000
Net tangible assets: 5330000
Owner earnings: -23279000
Return on net tangible assets (%): -436.75422138836774
Buffett classification: The Gruesome
Stock price: 0.51
Shares outstanding: 6406191
Book value: 7590000
P/B ratio: 0.43045552173913043
Market cap (USD): 3267157.41
Debt to equity: 0.3812911725955204
Current ratio: 3.0101275318829708
Quick ratio: 3.0101275318829708
Free cash flow (dilution-adjusted): -19080000
Buyback yield (%): 0
Retained earnings: -199824000
Capitalized R&D asset: 26644370
ROCI (R&D-adjusted, %): -62.61440325161247
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for MTNB — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -1946000
Net income: -1656000
Capital expenditures: 0
Operating cash flow: -2007000
Depreciation & amortization: 128000
Net tangible assets: 4010000
Owner earnings: -1528000
Return on net tangible assets (%): -38.104738154613464
Buffett classification: The Gruesome
Stock price: 0.52
Shares outstanding: 6406191
Book value: 6270000
P/B ratio: 0.5312949473684211
Market cap (USD): 3331219.3200000003
Debt to equity: 0.4328548644338118
Current ratio: 3.3467849223946784
Quick ratio: 3.3467849223946784
Free cash flow (dilution-adjusted): -2322000
Buyback yield (%): 0
Retained earnings: -201480000
Capitalized R&D asset: 85000
ROCI (R&D-adjusted, %): -19.15188376414935
Rule of 40 score: 0
Financial ratios for MTNB — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -1837000
Net income: -5245000
Capital expenditures: 0
Operating cash flow: -2021000
Depreciation & amortization: -98000
Net tangible assets: 5415000
Owner earnings: -5343000
Return on net tangible assets (%): -98.67036011080333
Buffett classification: The Gruesome
Stock price: 0.89
Shares outstanding: 6406191
Book value: 7675000
P/B ratio: 0.7428677511400652
Market cap (USD): 5701509.99
Debt to equity: 0.32964169381107494
Current ratio: 4.073991031390134
Quick ratio: 4.073991031390134
Free cash flow (dilution-adjusted): -2259000
Buyback yield (%): 0
Retained earnings: -206725000
Capitalized R&D asset: 56950
ROCI (R&D-adjusted, %): -19.23628907371218
Rule of 40 score: 0
Financial ratios for MTNB — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -1577000
Net income: -1532000
Capital expenditures: 0
Operating cash flow: -1474000
Depreciation & amortization: 331000
Net tangible assets: 4200000
Owner earnings: -1201000
Return on net tangible assets (%): -28.595238095238095
Buffett classification: The Gruesome
Stock price: 1.89
Shares outstanding: 6406191
Book value: 6460000
P/B ratio: 1.8742571191950463
Market cap (USD): 12107700.99
Debt to equity: 0.36130030959752324
Current ratio: 3.7812709030100335
Quick ratio: 3.7812709030100335
Free cash flow (dilution-adjusted): -1727000
Buyback yield (%): 0
Retained earnings: -208875000
Capitalized R&D asset: 28050
ROCI (R&D-adjusted, %): -19.510495601428445
Rule of 40 score: 0
Financial ratios for MTNB — annual report dated 2025-12-31
Total revenue: 0
Operating income: -6960000
Net income: -10345000
Capital expenditures: 0
Operating cash flow: -7011000
Depreciation & amortization: 456000
Net tangible assets: 2570000
Owner earnings: -9889000
Return on net tangible assets (%): -384.78599221789887
Buffett classification: The Gruesome
Stock price: 0.59
Shares outstanding: 6406191
Book value: 4830000
P/B ratio: 0.7825367888198758
Market cap (USD): 3779652.69
Debt to equity: 0.2803312629399586
Current ratio: 2.7853725222146273
Quick ratio: 2.7853725222146273
Free cash flow (dilution-adjusted): -8034000
Buyback yield (%): 0
Retained earnings: -210787000
Capitalized R&D asset: 12526480
ROCI (R&D-adjusted, %): -85.07247360367086
Rule of 40 score: 0
Financial ratios for MTNB — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -1600000
Net income: -1912000
Capital expenditures: 0
Operating cash flow: -1509000
Depreciation & amortization: 95000
Net tangible assets: 2570000
Owner earnings: -1817000
Return on net tangible assets (%): -70.70038910505836
Buffett classification: The Gruesome
Stock price: 0.59
Shares outstanding: 6406191
Book value: 4830000
P/B ratio: 0.7825367888198758
Market cap (USD): 3779652.69
Debt to equity: 0.2803312629399586
Current ratio: 2.7853725222146273
Quick ratio: 2.7853725222146273
Free cash flow (dilution-adjusted): -1726000
Buyback yield (%): 0
Retained earnings: -210787000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.8503046127067
Rule of 40 score: 0